CUE SCHEDULE 13G: SEC filing

Cormorant Asset Management, LP and Bihua Chen

Filed with the SEC on · accession 0001172661-26-005293

CUE filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -12.5% by the first close after the filing.

Summary of the filing

Cormorant Asset Management, LP and Bihua Chen filed a Schedule 13G reporting beneficial ownership of 791,377 shares (9.99%) of Cue Biopharma, including 625,285 shares of common stock and pre-funded warrants for up to 287,500 shares, subject to a 9.99% ownership cap.

Key details

Beneficial ownership shares$791K
Shares of common stock held$625K
Shares underlying pre-funded warrants$288K
Reporting person / beneficial ownerCormorant Asset Management, LP
IssuerCue Biopharma, Inc.
Managing member, cormorant asset management gp, llcBihua Chen

How CUE stock reacted

Close before

$16.12

Nov 13, 2026

First close after

-12.53%

$14.10

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CUE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CUE?

Click here

Frequently asked questions

What did CUE file with the SEC on Nov 16, 2026?

CUE filed a SCHEDULE 13G (SEC filing). Cormorant Asset Management, LP and Bihua Chen filed a Schedule 13G reporting beneficial ownership of 791,377 shares (9.99%) of Cue Biopharma, including 625,285 shares of common stock and pre-funded warrants for up to 287,500 shares, subject to a 9.99% ownership cap.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did CUE stock react to this filing?

CUE closed at $16.12 before the filing and $14.10 on Nov 16, 2026 (-12.53%).

Other CUE SEC filings

Get alerts when CUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days